The use of benzodiazepines for tinnitus: Systematic review

Journal of Laryngology and Otology

Volumn 129, Issue S3, 2015, Pages S14-S22

  Jufas, N E ^a   Wood, R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Benzodiazepines; Review; Tinnitus

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; OXAZEPAM; BENZODIAZEPINE RECEPTOR AFFECTING AGENT;

ARTICLE; DRUG EFFICACY; DRUG USE; HUMAN; SYSTEMATIC REVIEW; TINNITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

BENZODIAZEPINES; GABA MODULATORS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TINNITUS; TREATMENT OUTCOME;

EID: 84938985300     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215115000808     Document Type: Article

References (37)

1. Fioretti A, Eibenstein A, Fusetti M. New trends in tinnitus management. Open Neurol J 2011;5:12-17
2. Heller AJ. Classification and epidemiology of tinnitus. Otolaryngol Clin North Am 2003;36:239-48
3. Goebel G, Kahl M, Arnold W, Fichter M. 15-year prospective follow-up study of behavioral therapy in a large sample of inpatients with chronic tinnitus. Acta Otolaryngol 2006;126:70-9
4. Kalte nbach JA. The dorsal cochlear nucleus as a contributor to tinnitus: mechanisms underlying the induction of hyperactivity. Prog Brain Res 2007;166:89-106
5. Han S-S, Nam E-C, Won JY, Lee KU, Chun W, Choi HK et al. Clonazepam quiets tinnitus: a randomised crossover study with ginkgo biloba. J Neurol Neurosurg Psychiatry 2012;83:821-7
6. Sismanis A. Tinnitus. Curr Neurol Neurosci Rep 2001;1:492-9
7. Dobie RA. Depression and tinnitus. Otolaryngol Clin North Am 2003;36:383-8
8. Coroner s Court of Victoria. Finding into Death with Inquest: Inquest in the Death of David Andrew Trengrove. Melbourne: Coroners Court of Victoria, 2012
9. Lloyd B, Matthews S, Gao CX. Trends in Alcohol and Drug Related Ambulance Attendances in Victoria 2012/13. Fitzroy, Victoria: Turning Point, 2014
10. Australian Government, Department of Health, Therapeutic Goods Administration. Final decisions and reasons for decisions by delegates of the Secretary to the Department of Health and Ageing, June 2013. In: https://www.tga.gov.au/schedulingdecision-final/reasons-scheduling-delegates-final-decisions-june-2013 [5 March 2015]
11. MIMS Australia: MIMS Online. In: http://ww w.mimsonline. com.au [15 July 2014]
12. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. Int J Surg 2010 ;8:336-41
13. Higgins JPT, Altman DG, Sterne JAC, eds. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (update d March 2011). The Cochrane Collaboration (online), 2011
14. Bahmad FM, Venosa AR, Olivieira CA. Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin. Int Tinnitus J 2006;12:140-4
15. Lechtenberg R, Shulman A. Benzodiazepines in the treatment of tinnitus. J Laryngol Otol 1984;98:271-6
16. Kay NJ. Oral chemotherapy in tinnitus. Br J Audiol 1981;15: 123-4
17. Jalali MM, Kousha A, Naghavi SE, Soleimani R, Banan R. The effects of alprazolam on tinnitus: a cross-over randomized clinical trial. Med Sci Monit 2009;15:P155-60
18. Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus. Arch Otolaryngol Head Neck Surg 1993;119: 842-5
19. Aparecida de Azevedo A, Mello de Oliveira P, Gomes de Siqueira A, Figueiredo RR. A critical analysis of tinnitus measuring methods. Braz J Otorhinolaryngol 2007;73:418-23
20. Basile C-E, Fournier P, Hutchins S, Hébert S. Psychoacoustic assessment to improve tinnitus diagnosis. PLoS One 2013;8: e82995
21. Meikle MB, Vernon J, Johnson RM. The perceived severity of tinnit us. Some observations concerning a large population of tinnitus clinic patients. Otolaryngol Head Neck Surg 1984;92: 689-96
22. Baguley DM, Humphriss RL, Hodgson CA. Convergent validity of the tinnitus handicap inventory and the tinnitus questionnaire. J Laryngol Otol 2000;114:840-3
23. Langguth B, Goodey R, Azevedo A, Bjorne A, Cacace A, Crocetti A et al. Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006. Prog Brain Res 2007;166:525-36
24. Gopinath B, McMahon CM, Rochtchina E, Karpa MJ, M itchell P. Incidence, persistence, and progression of tinnitus symptoms in older adults: the Blue Mountains Hearing Study. Ear Hear 2010;31:407-12
25. Royal Australian and New Zealand College of Psychia trists Clinical Practice Guidelines Team for Panic Disorder and Agoraphobia. Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia. Aust N Z J Psychiatry 2003;37:641-56
26. Dassanayake T, Michie P, Carter G, Jones A. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-Analysis of epidemiological and experimental evidence. Drug Saf 2011; 34:125-56
27. Royal Australian and New Zealand College of Psychiatrists. Practice Guideline #5: Guidelines for Use of Benzodiazepines in Psychiatric Practice. Melbourne: Royal Australian and New Zealand College of Psychiat rists, 2008
28. Howard P, Twycross R, Shuster J, Mihalyo M, Wilcock A. Benzodiazepines. J Pain Symptom Manage 2014;47:955-64
29. O'Brien CP. Benzodiazepine use, abuse and dependence. J Clin Psychiatry 2005;66(suppl 2):28-33
30. Bliding A. The abuse potential of benzodiazepines with special reference to oxazepam. Acta Psychiatr Scand Suppl 1978;274: 111-16
31. Shulman A, Strashun AM, Seibyl JP, Daftary A, Goldstein B. Benzodiazepine receptor deficiency and tinnitus. Int Tinnitus J 2000;6:98-111
32. Bauer CA, Brozoski TJ, Holder TM, Caspary DM. Effects of chronic salicylate on GABAergic activity in rat inferior colliculus. Hear Res 2000;147:175-82
33. Simpson JJ, Davies WE. Recent advances in the pharmacological treatment of tinnitus. Trends Pharmacol Sci 1999;20:12-18
34. Darlington CL, Smith PF. Drug treatments for tinnitus. Prog Brain Res 2007;166:249-62
35. Malakouti SK, Nojomi M, Mahmoudian S, Alifattahi N, Salehi M. Comorbidity of chronic tinnitus and mental disorders. Int Tinnitus J 2011;16:118-22
36. Gananca MM, Caovilla HH, Gananca FF, Gananca CF, Munhoz MSL, Garcia da SilvaML et al. Clonazepamin the pharmacological treatment of vertigo and tinnitus. Int Tinnitus J 2002;8:50-3
37. Shulman A, Strashun AM, Goldstein BA. GABAA-benzodiazepine-chloride receptor-targeted therapy for tinnitus control: preliminary report. Int Tinnitus J 2002;8:30-6